Search for: "Pfizer, Inc."
Results 1361 - 1380
of 1,513
Sorted by Relevance
|
Sort by Date
23 Dec 2007, 8:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at [feeds.feedburner.com]GlobalEvents in Bali heap further pressure on all IP owners: (IAM),Velcro defies generic claim in domain name battle: (OUT-LAW),ICANN forms group to hasten non-English domain names: (IP Justice)WTO members continue debate on geographical indications register: (Intellectual Property Watch),Creative Commons launches CCo and CC programs: (World IP Day),Green IP Strategy - risks… [read post]
9 Apr 2015, 5:00 am
Bard, Inc., 2015 WL 502010, at *4 (S.D.W. [read post]
8 May 2008, 12:22 pm
Pfizer Inc., 358 F.3d 659 (9th Cir. 2004). [read post]
1 May 2024, 1:18 pm
”[20] The court explained that a defendant need not know of the AKS specifically — or intend to violate the AKS — they only have to know that the conduct was unlawful in some way.[21] The McKesson court emphasized that, in its view, this definition was fully in line with the Second Circuit’s 2022 decision in Pfizer Inc. v. [read post]
9 May 2008, 10:30 pm
: (Afro-IP), (Managing Intellectual Property), Rwanda: Four years after AIDS drugs bill passed, first low cost meds may head to Rwanda: (GenericsWeb), US: Abbott’s first quarter lobbying tab hits $880,000: (Patent Docs), US: House Bill would expand federal drug pedigree requirements and preempt state requirements: (FDA Law Blog), US: Purchasing Canadian drugs and patent infringement: Litecubes decision: (Patently-O), US: Neuralstem seeks to reopen stayed patent case… [read post]
9 Feb 2016, 6:27 am
Pfizer, Inc., 2000 WL 1738645 (S.D.N.Y. [read post]
7 Oct 2010, 5:00 am
Pfizer Inc., 249 F.R.D. 248, 254 n.8 (E.D. [read post]
15 Jul 2010, 2:39 pm
Wyeth, Inc., 613 F. [read post]
7 Feb 2008, 10:46 am
Medtronic, Inc., 231 F.3d 216, 230 (6th Cir. 2001).Kemp concluded that the purported "violations" before it were not violations at all - but merely reflected Plaintiffs' incorrect reading of FDA requirements. [read post]
22 Jan 2009, 2:06 am
Pfizer Inc., 358 F.3d 659, 661 (9th Cir. 2004) (same; physician considered warning inappropriate) (applying California law).Under these facts, if Conte were an ordinary prescription drug product liability case, plaintiff would have been out of court and out of luck, just like Motus. [read post]
29 Dec 2010, 12:54 pm
Wyeth, Inc. v. [read post]
8 Oct 2008, 11:50 am
Pfizer, Inc., 153 S.W.3d 758, 762 (Ky. 2004) (not a holding, but dictum suggesting broad comment k application).Louisiana: Kinney v. [read post]
17 May 2011, 10:37 pm
Align Technology, Inc., 463 F.3d 1299, 1311 (Fed. [read post]
28 Mar 2008, 6:00 am
: (Afro-IP),If education and pricing policy fail, says Adobe in Nigeria, we can still sue: (Afro-IP),South African arm of Chrysler objects to advertisement by Indian vehicle maker Mahindra and Mahindra that uses the term "jeep": (Afro-IP), (Spicy IP),Kenya’s call for anti-counterfeit legislation… amongst other changes: (Afro-IP),Kenya: Shared computer use raises privacy, confidentiality issues: (Afro-IP)AustraliaChanges to grace period for trade mark renewal:… [read post]
13 Apr 2014, 8:59 am
Pfizer Canada Inc., [2012] 3 S.C.R. 625 The patent system is based on a “bargain”, or quid pro quo: the inventor is granted exclusive rights in a new and useful invention for a limited period in exchange for disclosure of the invention so that society can benefit from this knowledge. [read post]
1 Dec 2017, 11:35 am
China’s Sanpower Group Co., Ltd. acquired Dendreon Pharmaceuticals Inc for $0.8 billion, and Sumitomo Dainippon Pharma Co., Ltd. acquired Tolero Pharmaceuticals Inc. for $0.8 billion to assist Sumitomo to refresh its pipeline.[28] In Q4 2017, a few M&A transactions have occurred in the pharma deal market. [read post]
23 Jan 2020, 10:37 pm
The phosphodiesterases 5 inhibitor medications (PDE5i) seem to arouse the litigation propensities of the lawsuit industry. [read post]
4 Jan 2010, 2:22 pm
Eric Affeldt, chief executive, ClubCorp Inc. [read post]
28 Apr 2011, 3:18 pm
By now Restatement (Second) of Torts §402A (1965) is so old as to be thought of as somewhat antediluvian. [read post]
19 Aug 2008, 10:35 pm
Vioxx came on the market in June 1999, after rival Pfizer Inc.'s Celebrex. [read post]
